2805 Overall survival gain with lenvatinib vs. placebo in radioactive iodine refractory differentiated thyroid cancer (RR-DTC): An updated analysis
EUROPEAN JOURNAL OF CANCER（2015）
Key words
thyroid cancer,radioactive iodine refractory,lenvatinib,rr-dtc
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined